Clinical Trial: Oral Propranolol Versus Fractional Carbon Dioxide CO2 Laser Assisted Delivery of Topical Timolol for Treatment of Infantile Hemangioma

U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT07560332) titled 'Oral Propranolol Versus Fractional Carbon Dioxide CO2 Laser Assisted Delivery of Topical Timolol for Treatment of Infantile Hemangioma' on April 24.

Brief Summary: To assess and compare the efficacy of systemic beta-blocker therapy with the efficacy and safety of fractional carbon dioxide laser-assisted delivery of a topical beta-blocker solution in the treatment of infantile hemangioma.

Study Start Date: Jan. 01, 2025

Study Type: INTERVENTIONAL

Condition: Infantile Hemangioma (IH)

Intervention: DRUG: Propranolol 1

oral propranolol is given daily in a dose of 1 to 2 mgekg daily for 3 months

DEVICE: Fractional CO2 laser with to...